Skip to main content

Gold-Functionalized Devices and Engineered Nanoparticles: Bioorthogonal Tools for Unprecedented Biomedical Applications

Project description

Catalytic nanoparticles for localised drug activation

In drug delivery, novel focal delivery approaches can supplement conventional delivery systems and prodrug strategies, preventing adverse effect and drug resistance, as well as increasing efficacy. The EU-funded GOLDEN project proposes to bypass the metabolic machinery of cells and produce bioactive molecules at specific locations within the body using metallic nanoparticles (NPs). Gold-based NPs serve as biocompatible catalysts and can be engineered to specifically reach cancer cells converting systemically administered bioactive precursors into drugs. Researchers will use zebrafish as a model to test the efficacy of the GOLDEN NP-based strategy at activating dyes and neuromodulators in the brain, paving the way for the treatment of localised disorders and chronic pain.


Net EU contribution
€ 212 933,76
Old College, South Bridge
EH8 9YL Edinburgh
United Kingdom

See on map

Eastern Scotland Edinburgh
Activity type
Higher or Secondary Education Establishments
Other funding
€ 212 933,76